Impact of Eplet-level anti-HLA antibodies on clinical outcomes after HSCT

Rui Murahashi, Shin-ichiro Fujiwara, Daisuke Minakata, Masahiro Ashizawa, Chihiro Yamamoto, Kaoru Hatano, Kazuya Sato, Ikuko Otsuki, Ken Ohmine, Yoshinobu Kanda

Open source

DOI: 10.1016/j.transci.2026.104549
Published: 2026-12
Container: Transfusion and Apheresis Science
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.transci.2026.104549,
  title = {Impact of Eplet-level anti-HLA antibodies on clinical outcomes after HSCT},
  author = {Rui Murahashi and Shin-ichiro Fujiwara and Daisuke Minakata and Masahiro Ashizawa and Chihiro Yamamoto and Kaoru Hatano and Kazuya Sato and Ikuko Otsuki and Ken Ohmine and Yoshinobu Kanda},
  year = {2026},
  journal = {Transfusion and Apheresis Science},
  doi = {10.1016/j.transci.2026.104549},
  url = {https://doi.org/10.1016/j.transci.2026.104549}
}

RIS

TY  - JOUR
TI  - Impact of Eplet-level anti-HLA antibodies on clinical outcomes after HSCT
AU  - Rui Murahashi
AU  - Shin-ichiro Fujiwara
AU  - Daisuke Minakata
AU  - Masahiro Ashizawa
AU  - Chihiro Yamamoto
AU  - Kaoru Hatano
AU  - Kazuya Sato
AU  - Ikuko Otsuki
AU  - Ken Ohmine
AU  - Yoshinobu Kanda
PY  - 2026
JO  - Transfusion and Apheresis Science
DO  - 10.1016/j.transci.2026.104549
UR  - https://doi.org/10.1016/j.transci.2026.104549
ER  -

APA

Murahashi, R., Fujiwara, S., Minakata, D., Ashizawa, M., Yamamoto, C., Hatano, K., Sato, K., Otsuki, I., Ohmine, K., & Kanda, Y. (2026). Impact of Eplet-level anti-HLA antibodies on clinical outcomes after HSCT. Transfusion and Apheresis Science. https://doi.org/10.1016/j.transci.2026.104549

Source records

crossref · retrieved 2026-11-09T21:34:26.735Z